Logo

pharmacogenomics

PGx Testing Reduces Adverse Drug Events, Multi-Site European Study Finds
Premium

The three-year Ubiquitous Pharmacogenomics Consortium's PREPARE study enrolled nearly 7,000 patients in seven European countries.

UCSF Health Set to Launch Clinical Pharmacogenetics Program
Premium

Doctors will be able to test patients for 17 genes known to influence response to 62 drugs and receive guidance from EHR-embedded pre- and post-test alerts.

EU Awards €4.8M to Support Transition of NGS Workflows to Clinical Settings
Premium

In the Instand-NGS4P program, a group of seven European hospitals are encouraging technology vendors to innovate by offering a path to IVDR compliance and a wide market for new products.

NewStem, MSK Innovation Hub Team to Validate Cancer Diagnostics Software Platform

The Israeli startup called this collaboration a necessary step toward commercializing its CE-marked NewStem Software Diagnostic Device for reducing oncology drug resistance.

NIH All of Us Program Returns First Health-Related Genetic Results to Participants
Premium

The All of Us Research Program began releasing ancestry and other nonclinical genetic results to participants in 2020 but will now return disease risk and PGx reports.

Dec 7, 2022

Intermountain Builds Up Bioinformatics to Make HerediGene Sequencing Data Clinically Actionable
Premium

Dec 2, 2022

UChicago Testing Pharmacogenomics for Surgical Patients in Clinical Trial
Premium

Nov 18, 2022

Avera Health Publishes Clinical Validation of PGx Panel for Depression Treatment Optimization
Premium

Nov 11, 2022

At AMIA, Clinical Decision Support Called Key to Wider PGx Use, Greater Efficacy
Premium

Oct 17, 2022

LetsGetChecked Eyeing Payors, Employers as Customers for New PGx Service
Premium

Sep 26, 2022

UK's NICE to Accelerate Assessment of Genedrive Test

Sep 7, 2022

Head and Neck Cancer Treatment Targets, Biomarkers Unearthed in Cell Model Analyses

Aug 30, 2022

UK's NICE to Assess Use of CYP2C19 Tests for Guiding Therapy Selection in Stroke Patients
Premium

Aug 18, 2022

Cancer Centers Nudge Oncologists Toward DPYD Testing as PGx Supporters Push For Guidelines Change
Premium

Aug 9, 2022

23andMe Pins Future on 'Genomic Health Service,' Therapeutic Development
Premium

Jun 1, 2022

Avera Health, Sema4 Launch Five-Year Precision Oncology Study

May 31, 2022

Nalagenetics Gets CE Mark for PGx Software Module

May 20, 2022

Tempus Takes on Precision Neuropsychiatry With New Research Dataset
Premium

May 5, 2022

Myriad Genetics Q1 Product Revenues Increase 3 Percent

Apr 13, 2022

Meditech Installs EHR Genomics Add-on at Health Systems in Pursuit of Precision Medicine
Premium

Apr 13, 2022

Mayo Clinic Study Bolsters Implementation of PGx Data in Clinical Practice
Premium

Apr 6, 2022

2bPrecise, Now Part of AccessDx, Wants to Bridge Genomic Lab Results, Clinical Decision Support
Premium

Apr 5, 2022

Castle Biosciences to Acquire AltheaDx for $65M

Mar 29, 2022

UK Report Urges Widespread NHS Uptake of Pharmacogenomics

Mar 25, 2022

Nalagenetics Closes $12.6M Series A Funding Round

Breaking News
The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.